Última Hora: "Motociclistas entregam manifesto na AR e recebem apoio do PCP - TSF Online" Sun, 18 Feb 2018 19:02:25 GMT    "Catarina Martins está hoje em Serpa - Rádio Pax" Sat, 17 Feb 2018 23:10:38 GMT    "?O mundo é bué cenas? e blockchain não é só criptomoedas - Shifter" Sat, 17 Feb 2018 16:57:37 GMT    "Luta pelos cargos de topo do BCE aquece. Espanha favorita no primeiro round - Dinheiro Vivo" Sun, 18 Feb 2018 07:48:52 GMT   "" Mon, 19 Feb 2018 06:38:19 GMT    "Ex-presidente do BES suspeito de ordenar pagamentos a políticos da Venezuela em troca de negócios - Observador" Sun, 18 Feb 2018 11:37:21 GMT    "Optimismo na bolsa afasta especuladores - Jornal de Negócios - Portugal" Mon, 19 Feb 2018 06:00:53 GMT    "Governo vai criar instrumento de segurança no arrendamento que proteja senhorios e inquilinos - Expresso" Fri, 16 Feb 2018 16:48:35 GMT    "Sindicatos confirmam cancelamento da greve na CP - TVI24" Sun, 18 Feb 2018 09:46:00 GMT    "Petróleo: panorama da semana de 19 a 23 de fevereiro - Investing.com Brasil" Sun, 18 Feb 2018 16:27:07 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Assets Stock

Loratadine Global Market 2018- Mylan, Sandoz, Sepracor
Assets Stock
The top players of Loratadine market are: Pfizer, GSK, Novartis India Limited, Mylan, Teva, Sandoz, Mayne Pharma Inc, Apollo Pharmaceuticals, Sepracor. On the basis of key regions, Loratadine report elaborates the regions like North America, Europe ...


GlobeNewswire (press release)

Spero Announces Appointment of David P. Southwell to its Board of Directors
GlobeNewswire (press release)
CAMBRIDGE, Mass., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant bacterial ...

e mais »

BioClin Therapeutics Appoints Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, MD, as ...
Business Wire (press release)
Dr. Currie has over 25 years of drug development experience in both pharmaceutical and biotechnology companies, having held senior leadership roles at Dynavax Technologies Corp., Regeneron Pharmaceuticals, Sepracor Inc. and PDL Biopharma. Dr. Abella ...

e mais »

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
Business Wire (press release)
... (USA), Inc. since September 2016, where he was instrumental in building the U.S. operations to support the company's regulatory and commercial strategy. Prior to joining Santhera U.S., Todd served as Executive Vice President and Chief Commercial ...

e mais »

Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors
Business Wire (press release)
Prior to that , he held roles as Executive Vice President and Chief Administrative and Legal Officer at Inspire Pharmaceuticals Inc., where he oversaw all matters related to legal, quality and compliance, corporate development and licensing and ...

e mais »

Minerva Neurosciences Names Richard Russell President
GlobeNewswire (press release)
He then served as President and Chief Executive Officer of Stallergenes Greer, Inc., the North American subsidiary of Stallergenes Greer, PLC. Previously, Mr. Russell was Executive Vice President and Chief Commercial Officer at Sunovion (formerly ...

e mais »

GlobeNewswire (press release)

Novelion Therapeutics Appoints Mark Corrigan, MD to Board of Directors
GlobeNewswire (press release)
Dr. Corrigan was previously president and chief executive officer of Zalicus Inc. Prior to that, he was executive vice president, research & development of Sepracor Inc. (now Sunovion Pharmaceuticals). Prior to joining Sepracor, Dr. Corrigan spent 10 ...

e mais »

Flex Pharma Reports Third Quarter 2017 Financial Results
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ:FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments in Phase 2 randomized, controlled trials for cramps and spasticity associated with severe neurological diseases such as ...

e mais »

Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by Dainippon ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications
GlobeNewswire (press release)
... Relations and Corporate Communications at HeartWare International, Inc., a leading innovator of less-invasive, miniaturized circulatory support technologies for advanced heart failure, which was acquired by Medtronic plc. Prior to HeartWare, Ms ...

e mais »

GlobeNewswire (press release)

VBL Therapeutics Announces the Appointments of Susan Kelley and David Hastings to Its Board of Directors
GlobeNewswire (press release)
From February 2000 to September 2003 Mr. Hastings served as Vice President, Chief Financial Officer and Treasurer of ArQule Inc. Prior to his employment with ArQule, Mr. Hastings was Vice President and Corporate Controller at Genzyme Inc., and Director ...

e mais »

Reuters

Dainippon to buy US drug firm Sepracor for $2.6 billion
Reuters
Dainippon will pay $23 cash for each share, a premium of 27.6 percent on Tuesday's close before media reports of the deal sent Sepracor's stock surging to $22.8 on Wednesday. The acquisition cost is roughly equal to Dainippon's annual sales. ?It's a ...
Dainippon Sumitomo Pharma to Acquire Sepracor for US $23.00 Per Share in an All-Cash Tender Offer Valued at ...FierceBiotech
Drugmaker Sepracor Accepts $2.6B Buyout Offer from Japan's DainipponXconomy

todos os 485 artigos de notícias »

Zacks Small Cap Research (press release)

PULM: Business And Financial Update For Third Quarter 2017
Zacks Small Cap Research (press release)
On November 9, 2017 Pulmatrix (NASDAQ:PULM) announced their third quarter financial results and provided operational highlights. Revenue of $0.3 million was recorded for the quarter which was related to the grant received from the Cystic Fibrosis ...


Business Wire (press release)

ArTara Therapeutics Announces Addition of Randall Marshall, MD as Chief Medical Officer
Business Wire (press release)
Prior to joining ArTara, Dr. Marshall led Retrophin, Inc.'s development of fosmetpantotenate, a replacement therapy for PKAN, an ultra-rare neurodegenerative disease. Under Dr. Marshall's leadership the program moved from first-in-man to pivotal trial ...

e mais »

Business Wire (press release)

Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Business Wire (press release)
MARLBOROUGH, Mass. & TORONTO--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) and Cynapsus Therapeutics Inc. (Cynapsus) (NASDAQ: CYNA) (TSX: CTH) today announced that the companies have signed a definitive agreement under which Sunovion will ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters